Archived - Important Drug Warning - Lamisil - (terbinafine Hcl) - Novartis

Lamisil (terbinafine HCL) Recall Summary Novartis is recalling Lamisil (terbinafine HCL) across Canada due to quality issues with the product. The recall affects patients who have been using this antifungal medication. Terbinafine is commonly prescribed to treat fungal infections of the skin and nails.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2001-05-17

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/08cdd519-eb8f-48b8-828e-e64cdd892a55